Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Ceribell, Inc. · Predicate Candidate Screening
15 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
120 daysmedian FDA review time
182 days90th percentile
15clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K261101 | Ceribell Monitor | Ceribell, Inc. | 2026-06-30 | 89 | 0 |
| K260998 | Ceribell Neurology Review Software | Ceribell, Inc. | 2026-06-24 | 90 | 0 |
| K260363 | Ceribell Brain Monitor Headband | Ceribell, Inc. | 2026-04-03 | 58 | 0 |
| K254033 | Ceribell Instant EEG Headset | Ceribell, Inc. | 2026-02-09 | 55 | 0 |
| K251936 | Ceribell Delirium Monitor System | Ceribell, Inc. | 2025-12-08 | 167 | 0 |
| K252070 | Ceribell Infant Seizure Detection Software | Ceribell, Inc. | 2025-11-21 | 143 | 0 |
| K251381 | Ceribell Instant EEG Headcap (Small: C251, Medium: C252) | Ceribell, Inc. | 2025-10-31 | 182 | 0 |
| K241589 | Ceribell Seizure Detection Software | Ceribell, Inc. | 2025-04-09 | 310 | 0 |
| K232052 | Ceribell Instant EEG Headband | Ceribell, Inc. | 2023-08-08 | 29 | 0 |
| K223504 | Ceribell Status Epilepticus Monitor | Ceribell, Inc. | 2023-05-23 | 182 | 0 |
| K223086 | Ceribell Instant EEG Headcap | Ceribell, Inc. | 2023-03-22 | 173 | 0 |
| K210805 | Ceribell Instant EEG Headband | Ceribell, Inc. | 2021-08-30 | 166 | 0 |
| K191301 | Ceribell Pocket EEG Device | Ceribell, Inc. | 2019-09-11 | 120 | 0 |
| K171459 | Ceribell Instant EEG Headband | Ceribell, Inc. | 2017-08-21 | 95 | 0 |
| K170363 | Ceribell Pocket EEG Device | Ceribell, Inc. | 2017-05-08 | 91 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda